GlassScriptPhysician profile
Marcia P Nelson
NPI 1760493647
$1,026.02
in general payments reported to CMS, 2019-2025
20 companies · $142 in 2025
The $142 reported for 2025 was more than what a typical Geriatric Medicine (Internal Medicine) provider received nationally (typical 2025 total: $123).
See the full distribution for Geriatric Medicine (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.75 · 2020: $18.27 · 2021: $206 · 2022: $319 · 2023: $202 · 2024: $118 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $462.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $461.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $408.98 | 2022-2025 | |
| Calliditas Therapeutics US INC. | $81.19 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $59.29 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $57.79 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $42.23 | 2022 | |
| Abbvie INC. | $38.85 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $38.29 | 2021-2023 | |
| Avanir Pharmaceuticals, INC. | $35.90 | 2021 | |
| Ucb, INC. | $31.49 | 2021 | |
| Exact Sciences Corporation | $26.30 | 2025 | The Cologuard Plus Collection Kit |
| Alnylam Pharmaceuticals INC. | $25.09 | 2022 | |
| Genentech USA, INC. | $24.41 | 2021 | |
| Madrigal Pharmaceuticals | $23.68 | 2025 | Rezdiffra |
| Vanda Pharmaceuticals INC. | $21.08 | 2025 | Ponvory |
| Sunovion Pharmaceuticals INC. | $20.75 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $19.93 | 2021 | |
| Xeris Pharmaceuticals, INC. | $19.05 | 2025 | Gvoke Hypopen |
| Amgen INC. | $18.27 | 2020 | |
| Aurinia Pharma U.S., INC. | $17.23 | 2021 | |
| Jazz Pharmaceuticals INC. | $16.22 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcia Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.